Delivery Order SPE2DB24D9238-SPE2DB25FDQXF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,475.16 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of VABYSMO 6 mg/0.05 ml syringes. VABYSMO is a prescription pharmaceutical product used in ophthalmology for treating retinal conditions. The delivery order is firm fixed price with no set-aside designation and is scheduled for ultimate completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- The Defense Logistics Agency (DLA), functioning as part of the Department of Defense's Medical Supply Chain, awarded a delivery order valued at $8,655.50 to DMS Pharmaceutical Group Inc. for the supply of VABYSMO 6MG/0.05ML. This firm fixed-price delivery order, issued on June 25, 2025, with an ultimate completion date of the same day, represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award was made...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,933.76 on July 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. The award carries an ultimate completion date of August 8, 2025, and represents a specific delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- The Defense Logistics Agency awarded a $29,168 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The award, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the pharmaceutical product to support...
- The Defense Logistics Agency awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. on April 23, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order, issued without set-aside designation, is scheduled for completion by May 14, 2025, and will be performed at the vendor's location in Park Ridge, Illinois. Vabysmo is a prescription medication used in ophthalmology for treating certain retinal conditions, and this order represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,917.20 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, covers the supply of Vabysmo 6 mg/0.05 mL syringes for delivery to Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the contractor to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQXFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. for VABYSMO 6 mg/0.05 ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct procurement of pharmaceutical supplies to support military healthcare operations. VABYSMO is a prescription ophthalmic medication used in treating age-related macular degeneration, and this delivery will be fulfilled from the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group Inc.'s existing indefinite delivery contract (IDC) with the DLA valued at approximately $500 million through November 2026. As a woman-owned small business pharmaceutical wholesaler, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's extensive contract portfolio with the DLA demonstrates its capability to reliably supply diverse pharmaceutical products meeting the specialized medical needs of military health systems across the globe.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/22/25 |